C Haškovec

657 total citations
35 papers, 487 citations indexed

About

C Haškovec is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, C Haškovec has authored 35 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Hematology and 7 papers in Genetics. Recurrent topics in C Haškovec's work include Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). C Haškovec is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). C Haškovec collaborates with scholars based in Czechia, Vietnam and Poland. C Haškovec's co-authors include Arnošt Kotyk, J. Kocourek, Václav Hořejšı́, K Michalová, Jana Marková, Jana Moravcová, Jan Starý, Hana Klamová, Jiřı́ Schwarz and Jaroslav Čermák and has published in prestigious journals such as Blood, European Journal of Biochemistry and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

C Haškovec

34 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Haškovec Czechia 13 294 182 71 71 57 35 487
André Sels Belgium 10 239 0.8× 309 1.7× 205 2.9× 60 0.8× 33 0.6× 18 629
J B Lum United States 6 206 0.7× 136 0.7× 54 0.8× 71 1.0× 17 0.3× 7 481
Daniel Hart United States 9 307 1.0× 101 0.6× 69 1.0× 50 0.7× 38 0.7× 11 569
Nasséra Aouali Luxembourg 13 456 1.6× 52 0.3× 60 0.8× 130 1.8× 63 1.1× 15 676
Linping Hu China 14 303 1.0× 138 0.8× 67 0.9× 61 0.9× 94 1.6× 29 589
Philip J. French United Kingdom 11 224 0.8× 40 0.2× 22 0.3× 46 0.6× 103 1.8× 15 376
G S Adrian United States 10 439 1.5× 77 0.4× 36 0.5× 36 0.5× 19 0.3× 16 609
Bastian Hoffmann Germany 6 379 1.3× 86 0.5× 26 0.4× 13 0.2× 39 0.7× 7 627
Matthew Sullivan United States 12 303 1.0× 59 0.3× 37 0.5× 83 1.2× 10 0.2× 21 510
Tao Zhen United States 12 365 1.2× 137 0.8× 31 0.4× 68 1.0× 22 0.4× 28 468

Countries citing papers authored by C Haškovec

Since Specialization
Citations

This map shows the geographic impact of C Haškovec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Haškovec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Haškovec more than expected).

Fields of papers citing papers by C Haškovec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Haškovec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Haškovec. The network helps show where C Haškovec may publish in the future.

Co-authorship network of co-authors of C Haškovec

This figure shows the co-authorship network connecting the top 25 collaborators of C Haškovec. A scholar is included among the top collaborators of C Haškovec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Haškovec. C Haškovec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burda, Pavel, Vít Pospíšil, Monika Beličková, et al.. (2012). 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity. Leukemia. 26(8). 1804–1811. 36 indexed citations
2.
3.
Marková, Jana, C Haškovec, Ota Fuchs, et al.. (2012). Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation. Leukemia Research. 36(9). 1128–1133. 40 indexed citations
4.
Marková, Jana, et al.. (2011). Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression. Experimental and Therapeutic Medicine. 3(1). 129–133. 10 indexed citations
5.
6.
Klamová, Hana, I Janatková, I Šterzl, et al.. (2006). Immunological Profiles of Patients with Chronic Myeloid Leukaemia. I. State before the Start of Treatment. Folia Biologica. 52(3). 47–58. 15 indexed citations
7.
Haškovec, C, et al.. (2004). Gene expression during camptothecin-induced apoptosis in human myeloid leukemia cell line ML-2.. PubMed. 51(3). 175–80. 8 indexed citations
8.
Haškovec, C, et al.. (2003). The Use of Housekeeping Genes (HKG) as an Internal Control for the Detection of Gene Expression by Quantitative Real-Time RT-PCR. Folia Biologica. 49(6). 211–216. 43 indexed citations
9.
Polák, J., Šoňa Peková, James K. Schwarz, Tomáš Kozák, & C Haškovec. (2003). [Expression of cyclin-dependent kinase inhibitors in leukemia].. PubMed. 142(1). 25–8. 2 indexed citations
10.
Souček, Josef, et al.. (2003). Relationship between cyclin D1 and p21Waf1/Cip1 during differentiation of human myeloid leukemia cell lines. Leukemia Research. 27(12). 1115–1123. 29 indexed citations
11.
Michalová, K, Zuzana Zemanová, Jana Březinová, et al.. (2002). Location of the BCR/ABL Fusion Genes on Both Chromosomes 9q34 in Ph Negative Chronic Myeloid Leukemia. Leukemia & lymphoma. 43(8). 1695–1700. 9 indexed citations
12.
Schwarz, Jiřı́, Adam Jirásek, Marek Trněný, et al.. (2001). Aleukemic granulocytic sarcoma with AML1/ETO fusion gene expression and clonal T cell populations. Leukemia Research. 25(12). 1137–1142. 3 indexed citations
13.
Trka, Jan, Jan Zuna, C Haškovec, et al.. (1999). [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].. PubMed. 138(1). 12–7. 6 indexed citations
14.
Moravcová, Jana, et al.. (1998). Simple competitive two-step RT-PCR assay to monitor minimal residual disease in CML patients after bone marrow transplantation. Leukemia. 12(8). 1303–1312. 26 indexed citations
15.
Haškovec, C, Carola Ponzetto, Jaroslav Poläk, et al.. (1998). P230 BCR/ABL protein may be associated with an acute leukaemia phenotype. British Journal of Haematology. 103(4). 1104–1108. 32 indexed citations
16.
Haškovec, C, P Lemež, R Neuwírtová, Jamie Wilhelm, & Petr Jarolı́m. (1990). Differentiation of human myeloid leukemia cell line ML-1 induced by retinoic acid and 1,25-dihydroxyvitamin D3.. PubMed. 37(5). 565–72. 3 indexed citations
17.
Haškovec, C, et al.. (1988). Acrylonitrile depletes glutathione without changing calcium sequestration in hepatic microsomes and mitochondria. Toxicology. 48(1). 87–92. 3 indexed citations
18.
Haškovec, C, et al.. (1985). Rubidium Transport in X-irradiated Human Erythrocytes. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 48(5). 773–783. 1 indexed citations
19.
Jarolı́m, Petr, et al.. (1985). Estimation of membrane fluidity of X-irradiated human lymphocytes.. PubMed. 26(3). 299–304. 3 indexed citations
20.
Haškovec, C, et al.. (1976). Interaction of lectins with surface membrane receptors of animal cells. I. Factors responsible for agglutinability of human, rabbit, and sheep erythrocytes with concanavalin A.. PubMed. 22(4). 225–34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Sels Breakdown of academic impact, for papers by J B Lum Breakdown of academic impact, for papers by Daniel Hart Breakdown of academic impact, for papers by Nasséra Aouali Breakdown of academic impact, for papers by Linping Hu Breakdown of academic impact, for papers by Philip J. French Breakdown of academic impact, for papers by G S Adrian Breakdown of academic impact, for papers by Bastian Hoffmann Breakdown of academic impact, for papers by Matthew Sullivan Breakdown of academic impact, for papers by Tao Zhen
Rankless by CCL
2026